Navigation Links
Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Oral Picoplatin Demonstrating Bioavailability
Date:4/21/2009

atinum chemotherapy drugs. Picoplatin has demonstrated anti-tumor activity in a variety of solid tumors. It is being studied in multiple cancer indications, treatment combinations and by two routes of administration.

Poniard is currently evaluating the efficacy and safety of picoplatin in SCLC in the pivotal Phase 3 SPEAR (Study of Picoplatin Efficacy After Relapse) trial, which is being conducted under a Special Protocol Assessment agreement with the U.S. Food and Drug Administration. The Company reached its enrollment target in this international, multi-center, randomized, controlled trial in March 2009. Poniard is also evaluating picoplatin in two Phase 2 clinical trials -- one in patients with metastatic CRC and the other in patients with castration-resistant (or hormone-refractory) prostate cancer.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. For additional information please visit http://www.poniard.com.

This release contains forward-looking statements, including statements regarding the Company's results of clinical trials, business objectives and strategic goals, drug development plans, the potential safety and efficacy of its products in development and commercialization strategy. The Company's actual results may differ materially from those indicated in these forward-looking statements based on a number of factors, including risks and uncertainties associated with the Company's research and development activities; the results of clinical testing; the receipt and timing of FDA and other required regulatory approvals; the market's acceptance of the Company's proposed products; the Company's anticipated operating l
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Poniard Pharmaceuticals Announces Upcoming Conference Participation
2. Poniard Pharmaceuticals Reports Second Quarter 2008 Financial Results and Corporate Update
3. Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update
4. Poniard Pharmaceuticals Provides 2009 Clinical Data Goals for Picoplatin
5. Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer
6. Poniard Pharmaceuticals Receives Going Concern Qualification
7. Poniard Pharmaceuticals to Present at Needham & Companys Cancer Therapeutics: Today & Tomorrow Conference
8. Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization
9. Poniard Announces Publication of Results of Picoplatin Phase 2 Study in Journal of Clinical Oncology
10. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
11. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... July 25, 2014 Mahendra Trivedi and ... Online Workshop ‘Consciousness is Power’ on Saturday, July 26, ... to attend this life transforming event as they will ... higher level. Few days are left for the commencement ... Trivedi and Trivedi Masters™ Dahryn Trivedi (his wife) and ...
(Date:7/25/2014)... CMS recently has imposed a series ... inadequate access to prescription drugs. Agency audits are uncovering ... safety of beneficiaries in areas such as rejected pharmacy ... is taking quick and firm actions to halt them. ... “Avoiding Costly Part D Sanctions: Rx Access Strategies ...
(Date:7/25/2014)... 25, 2014 Yisrayl Hawkins, Pastor and Overseer ... on his blog explaining why so many prayers are going ... , In the article, Yisrayl gives many examples around ... the results. For example, in one case, in the small ... grounds to pray for rain; ironically, they received a massive ...
(Date:7/25/2014)... Yisrayl Hawkins, Pastor and Overseer of The House of Yahweh ... revealing to the whole world, including even the most devout ... in his new article. , Yisrayl says it all started ... by the Catholic Church. He says this plan included removing ... and replacing it with titles such as Lord and God. ...
(Date:7/25/2014)... According to the Hemorrhoid ... Vkool.com, this is a comprehensive guide that ... common types of hemorrhoids including:, ...     Young children with hemorrhoids , ...     Very large hemorrhoids and chronic hemorrhoids , ...
Breaking Medicine News(10 mins):Health News:Mahendra Trivedi to Host an Online Workshop ‘Consciousness is Power’ 2Health News:Mahendra Trivedi to Host an Online Workshop ‘Consciousness is Power’ 3Health News:Aug. 5 Webinar to Offer Strategies for Preventing Rx Access Issues and Avoiding Part D Sanctions 2Health News:Yisrayl Hawkins Says Prayers for Rain Result in Violent Hail Because Prayers Are Not Being Heard in New Post 2Health News:Yisrayl Hawkins Says Prayers for Rain Result in Violent Hail Because Prayers Are Not Being Heard in New Post 3Health News:Yisrayl Hawkins Says You Have Been Tricked Into Worshipping Satan in New Article 2Health News:Hemorrhoid No More Pdf Review Exposes Jessica Wright's Guide For Treating Hemorrhoids – Vkool.com 2Health News:Hemorrhoid No More Pdf Review Exposes Jessica Wright's Guide For Treating Hemorrhoids – Vkool.com 3
... SANTA MONICA, Calif., Oct. 8 Proposed,regulations that ... California stem cell research grants to for-profit organizations ... cures for California taxpayers,paying for the research, the ... "To ensure that the people who have ...
... Precise Surgical Laser Procedures, CAMBRIDGE, Mass., Oct. ... laser fibers for precision surgery, announced today,the launch ... procedures. The LightPath fiber features a fine ... safely conduct more precise procedures in Laryngology,Head & ...
... their own ... personal health info, PHILADELPHIA, Oct. ... largest organization of its,kind, will ask select groups of Americans to ... for,themselves, their children and ailing loved ones. At its 79th Annual,Convention ...
... like most, you eat worst at healthy restaurants., The ... treat themselves to higher-calorie side dishes, drinks or desserts ... no health claims, according to a series of new ... version of the Journal of Consumer Research , ...
... patients more likely to develop dementia, study finds ... people with Parkinson,s disease face up to a 73 ... new study that says genetics could be to blame. ... central nervous system, such as impaired motor skills and ...
... New research shows that selective serotonin reuptake inhibitors ... depression, may double the risk of gastrointestinal bleeding, according ... and colleagues. When the drugs are taken with aspirin ... than 600 percent higher. , Clinicians who prescribe these ...
Cached Medicine News:Health News:Revised California Stem Cell Research Rules Fail to Ensure Affordable Access to Cures, Consumers Warn 2Health News:OmniGuide Announces Launch of LightPath(TM) CO2 Laser Fiber 2Health News:AHIMA National Consumer Awareness Campaign Urges Patients to Assume Responsibility of Personal Health Records 2Health News:'Healthy' restaurants help make us fat, says a new Cornell study 2Health News:Parkinson's Linked to Risk of Alzheimer's 2Health News:Anti-depressant drugs can double risk of gastrointestinal bleeding 2Health News:Anti-depressant drugs can double risk of gastrointestinal bleeding 3
(Date:7/25/2014)... Dr. Michael Gabriel of a prominent Staten ... study, which shows how grief in pregnancy may cause obesity ... According to US News , "Unborn children ... others to grow up overweight or obese, even if that ... specific types of stress that caused obesity: "Children whose biological ...
(Date:7/24/2014)... 2014   AcelRx Pharmaceuticals, Inc.  (Nasdaq: ... development and commercialization of innovative therapies for the treatment ... date for Zalviso remains July 27, 2014.  ... stating the Food and Drug Administration (FDA) had approved ... no notification to the company from the FDA regarding ...
(Date:7/24/2014)... PARK, Kan. , July 24, 2014 /PRNewswire/ ... of two compounds that will be added to ... with Australian-based CIMTECH Pty Ltd, a biotechnology company. ... PAR 122 have shown promise in bone regeneration ... license to develop the compounds for the veterinary ...
Breaking Medicine Technology:Dr. Michael Gabriel of GPM Pediatrics, a Noted Staten Island Pediatrics Clinic, Comments on Study, Which Names Grief as a Cause of Obesity in Children 2AcelRx Pharmaceuticals Confirms July 27, 2014 PDUFA Date for Zalviso 2Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 2Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 3Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 4
Silicone Foley Catheters 2-Way (Pediatric)...
Midstream Catch Kits...
Midstream Catch Kits...
... The Pediatric BladderScan® ... to Diagnostic Ultrasound's trusted ... By enabling healthcare providers ... bladder volume noninvasively, this ...
Medicine Products: